Shih Alvin
SEC insider (Form 3/4/5 filer). CIK 0001610064. Director at ZEVRA THERAPEUTICS, INC. (ZVRA) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in BOSTON, MA.
Companies Shih Alvin has filed insider reports for
- ZEVRA THERAPEUTICS, INC. (ZVRA): Director
- Oaktree Acquisition Corp. III Life Sciences (OACC): Director
Shih Alvin
CIK: 0001610064
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 4, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
30K shares- - Sep 12, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
PurchaseDirect20K shares at avg. $7.89$158K - May 29, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
30K shares-
1-3 of 3 transactions